Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphism of Angiotensin-Converting Enzyme is not associated with the development of Parkinson's disease and of L-dopa-induced adverse effects.

Journal of the neurological sciences - 15 Jan 2009

Pascale Esterina, Purcaro Carlo, Passarelli Emanuela, Guglielmi Renzo, Vestri Anna Rita, Passarelli Francesca, Meco Giuseppe

Abstract excerpt

Sporadic Parkinson's disease (PD) is a frequent neurodegenerative movement disorder. Both environmental and genetic factors have been studied in the etiology of PD. Among genetic factors, increasing evidences suggest that deletion/insertion (D/I) gene polymorphism of the angiotensin I-converting enzyme (ACE) may be involved in the pathogenesis of PD and in the occurrence of the adverse effects of chronic L-dopa...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antiparkinson Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Levodopa

Share to Parkinson Disease

Share to Peptidyl-Dipeptidase A

Share to Polymorphism, Genetic

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 18805557
DOI: 10.1016/j.jns.2008.08.017

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphism of Angiotensin-Converting Enzyme is not associated with the development of Parkinson's disease and of L-dopa-induced adverse effects.PMID 18805557Read ↗

Genetic polymorphism of the angiotensin converting enzyme and L-dopa-induced adverse effects in Parkinson's disease.Semantic proximity Read ↗

Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson's disease.Semantic proximity Read ↗

The angiotensin-converting enzyme (ACE) I/D polymorphism in Parkinson's disease.Semantic proximity Read ↗

The ACE deletion polymorphism is not associated with Parkinson's disease.Semantic proximity Read ↗

Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson's disease.Semantic proximity Read ↗

Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease.Semantic proximity Read ↗

Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis.Semantic proximity Read ↗

Apolipoprotein E (APOE), PARKIN and catechol-O-methyltransferase (COMT) genes and susceptibility to sporadic Parkinson's disease in Finland.Semantic proximity Read ↗

Interleukin-10 gene polymorphism in Parkinson's disease patients.Semantic proximity Read ↗

Apolipoprotein E polymorphisms and Parkinson's disease.Semantic proximity Read ↗

Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders.Semantic proximity Read ↗

No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.